Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EZR pseudogene 1 is a non-coding genomic locus that shares sequence similarity with the protein-coding EZR gene (ezrin), but carries mutations or lacks regulatory elements necessary for gene expression and protein-coding function. Such pseudogenes are classified based on origin (processed, unprocessed, or unitary), and may participate in RNA-level regulation, such as miRNA competition, influencing the expression levels of their parent or related genes. While pseudogenes have emerging roles in gene regulatory networks and may have indirect relevance in diseases such as cancer through their regulatory RNA products, EZRP1 itself does not encode a functional protein nor is it targeted for therapeutic intervention[4][5][7].
Not applicable. No drugs are known to act via or on EZRP1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EZR pseudogene 1 (EZRP1).